VF, T. (2023). Cervicovaginal Papanicolaou tests in transgender men: Cytomorphologic alterations, interpretation considerations, and clinical implications. Cancer cytopathology, 131(10), 626. https://doi.org/10.1002/cncy.22731
Chicago Style (17th ed.) CitationVF, Torous. "Cervicovaginal Papanicolaou Tests in Transgender Men: Cytomorphologic Alterations, Interpretation Considerations, and Clinical Implications." Cancer Cytopathology 131, no. 10 (2023): 626. https://doi.org/10.1002/cncy.22731.
MLA (9th ed.) CitationVF, Torous. "Cervicovaginal Papanicolaou Tests in Transgender Men: Cytomorphologic Alterations, Interpretation Considerations, and Clinical Implications." Cancer Cytopathology, vol. 131, no. 10, 2023, p. 626, https://doi.org/10.1002/cncy.22731.